Pressure Redistribution Surfaces (e.g., Alternating Pressure Mattress)
Treatment for Decubitus Ulcer
Typical Dosage: Continuous use
Effectiveness
90%
Safety Score
95%
Clinical Trials
300
Participants
35K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
95
DangerousModerateSafe
Treatment Details
Dosage Range
Continuous use
Time to Effect
Immediate pressure reduction, wound healing visible in weeks
Treatment Duration
Continuous until healing, then long-term for prevention
Evidence Quality
HIGHNumber Needed to Treat (NNT)
8(Treat 8 patients to see 1 additional successful outcome)
Confidence Score
92%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$300
Side Effect Mgmt:$100
Total Annual:$400
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$30,000/QALY
QALYs Gained
0.4
Outcome-Based Costs
Cost per Responder
$2,142.86
Cost per Remission
$2,500
Pressure Redistribution Surfaces (e.g., Alternating Pressure Mattress) Outcomes
for Decubitus Ulcer
Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+70%
Remission Rate
+60%
Common Side Effects
Skin irritation from moisture
+3%
Device malfunction
+1%
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov